106 related articles for article (PubMed ID: 37669874)
21. Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.
Wu L; Gao L; Kong D; Xue H
Dig Dis Sci; 2019 Nov; 64(11):3164-3172. PubMed ID: 31041642
[TBL] [Abstract][Full Text] [Related]
22. Targeted protein degradation: mechanisms, strategies and application.
Zhao L; Zhao J; Zhong K; Tong A; Jia D
Signal Transduct Target Ther; 2022 Apr; 7(1):113. PubMed ID: 35379777
[TBL] [Abstract][Full Text] [Related]
23. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.
Mishra I; Xie WR; Bournat JC; He Y; Wang C; Silva ES; Liu H; Ku Z; Chen Y; Erokwu BO; Jia P; Zhao Z; An Z; Flask CA; He Y; Xu Y; Chopra AR
Cell Metab; 2022 Apr; 34(4):549-563.e8. PubMed ID: 35298903
[TBL] [Abstract][Full Text] [Related]
24. LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain.
Cornejo F; Cortés BI; Findlay GM; Cancino GI
Front Cell Dev Biol; 2021; 9():659951. PubMed ID: 34966732
[TBL] [Abstract][Full Text] [Related]
25. Gamma-Secretase Inhibitor (DAPT), a potential therapeutic target drug, caused neurotoxicity in planarian regeneration by inhibiting Notch signaling pathway.
Dong Z; Huo J; Liang A; Chen J; Chen G; Liu D
Sci Total Environ; 2021 Aug; 781():146735. PubMed ID: 33812110
[TBL] [Abstract][Full Text] [Related]
26. PTPRA facilitates cancer growth and migration via the TNF-α-mediated PTPRA-NF-κB pathway in MCF-7 breast cancer cells.
Lin C; Xin S; Huang X; Zhang F
Oncol Lett; 2020 Nov; 20(5):131. PubMed ID: 32934700
[TBL] [Abstract][Full Text] [Related]
27. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
[TBL] [Abstract][Full Text] [Related]
28. c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?
Belli S; Esposito D; Servetto A; Pesapane A; Formisano L; Bianco R
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517369
[TBL] [Abstract][Full Text] [Related]
29. RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain.
Wen Y; Yang S; Wakabayashi K; Svensson MND; Stanford SM; Santelli E; Bottini N
J Biol Chem; 2020 Apr; 295(15):4923-4936. PubMed ID: 32139509
[TBL] [Abstract][Full Text] [Related]
30. The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.
Tomita H; Cornejo F; Aranda-Pino B; Woodard CL; Rioseco CC; Neel BG; Alvarez AR; Kaplan DR; Miller FD; Cancino GI
Cell Rep; 2020 Jan; 30(1):215-228.e5. PubMed ID: 31914388
[TBL] [Abstract][Full Text] [Related]
31. Development of therapeutic antibodies for the treatment of diseases.
Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
[TBL] [Abstract][Full Text] [Related]
32. Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.
Bloch E; Sikorski EL; Pontoriero D; Day EK; Berger BW; Lazzara MJ; Thévenin D
J Biol Chem; 2019 Dec; 294(49):18796-18806. PubMed ID: 31676686
[TBL] [Abstract][Full Text] [Related]
33. Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential.
Rivera-Torres J; San José E
Front Pharmacol; 2019; 10():1011. PubMed ID: 31619990
[TBL] [Abstract][Full Text] [Related]
34. A head-to-toe dimerization has physiological relevance for ligand-induced inactivation of protein tyrosine receptor type Z.
Fujikawa A; Sugawara H; Tanga N; Ishii K; Kuboyama K; Uchiyama S; Suzuki R; Noda M
J Biol Chem; 2019 Oct; 294(41):14953-14965. PubMed ID: 31416834
[TBL] [Abstract][Full Text] [Related]
35. Dasatinib in breast cancer: Src-ing for response in all the wrong kinases.
Kennedy LC; Gadi V
Ann Transl Med; 2018 Nov; 6(Suppl 1):S60. PubMed ID: 30613635
[No Abstract] [Full Text] [Related]
36. Phosphatases start shedding their stigma of undruggability.
Mullard A
Nat Rev Drug Discov; 2018 Nov; 17(12):847-849. PubMed ID: 30482950
[No Abstract] [Full Text] [Related]
37. Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Uhl GR; Martinez MJ; Paik P; Sulima A; Bi GH; Iyer MR; Gardner E; Rice KC; Xi ZX
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11597-11602. PubMed ID: 30348770
[TBL] [Abstract][Full Text] [Related]
38. Gamma-secretase-dependent signaling of receptor tyrosine kinases.
Merilahti JAM; Elenius K
Oncogene; 2019 Jan; 38(2):151-163. PubMed ID: 30166589
[TBL] [Abstract][Full Text] [Related]
39. Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.
Lichtenthaler SF; Lemberg MK; Fluhrer R
EMBO J; 2018 Aug; 37(15):. PubMed ID: 29976761
[TBL] [Abstract][Full Text] [Related]
40. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion.
Mauthe M; Orhon I; Rocchi C; Zhou X; Luhr M; Hijlkema KJ; Coppes RP; Engedal N; Mari M; Reggiori F
Autophagy; 2018; 14(8):1435-1455. PubMed ID: 29940786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
